Copertina

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Steffi De Meyer, Elena R. Blujdea, Jolien M. Schaeverbeke, Katarzyna Adamczuk, Rik Vandenberghe, Koen Poesen, Charlotte E. Teunissen
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
di: Sebastiaan De Keersmaecker, et al.
Pubblicazione: (2024)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
di: Robert Perneczky, et al.
Pubblicazione: (2025)

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
di: Thomas Claessen, et al.
Pubblicazione: (2026)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
di: Katharina Bolsewig, et al.
Pubblicazione: (2024)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
di: Thomas Claessen, et al.
Pubblicazione: (2025)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
di: Frederikke Kragh Clemmensen, et al.
Pubblicazione: (2026)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
di: Lars Frings, et al.
Pubblicazione: (2025)

Association between BrainAGE and Alzheimer's disease biomarkers
di: Yousaf Abughofah, et al.
Pubblicazione: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
di: Sofia Toniolo, et al.
Pubblicazione: (2024)

Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting
di: Rebecca Z. Rousset, et al.
Pubblicazione: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
di: Darren M. Lipnicki, et al.
Pubblicazione: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
di: Soheil Mohammadi, et al.
Pubblicazione: (2025)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
di: Faheem Arshad, et al.
Pubblicazione: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
di: Emily K. Schworer, et al.
Pubblicazione: (2024)

Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease
di: Alireza Shaabanpoor Haghighi, et al.
Pubblicazione: (2025)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
di: Christopher Gonzalez Corona, et al.
Pubblicazione: (2026)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
di: Patrick H. Luckett, et al.
Pubblicazione: (2026)

Peripheral oxidative stress related biomarkers in Alzheimer's disease: A systematic review of their implications for diagnosis and disease monitoring
di: George Nkrumah Osei, et al.
Pubblicazione: (2026)

Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant
di: Anneka E. Blankenship, et al.
Pubblicazione: (2024)

Correction to "Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease"
Pubblicazione: (2025)

A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
di: Sara Teijeira‐Portas, et al.
Pubblicazione: (2026)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
di: Willa D. Brenowitz, et al.
Pubblicazione: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
di: Ihab Hajjar, et al.
Pubblicazione: (2024)

Blood biomarkers for Alzheimer's disease: Reliable change and impacts of renal and blood–brain barrier function
di: Anders Behrens, et al.
Pubblicazione: (2025)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
di: Juliana N. Souza‐Talarico, et al.
Pubblicazione: (2025)

Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States
di: Sephira Ryman, et al.
Pubblicazione: (2026)

Systematic review and evidence gap mapping of Alzheimer's disease biomarker studies in those with intellectual and developmental disability
di: Lubnaa Abdullah, et al.
Pubblicazione: (2025)

Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
di: Dustin B. Hammers, et al.
Pubblicazione: (2026)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
di: Alexandra Paget‐Blanc, et al.
Pubblicazione: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
di: Sunu Mathew, et al.
Pubblicazione: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
di: Iolanda Lázaro, et al.
Pubblicazione: (2024)

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
di: Sonja M. Kagerer, et al.
Pubblicazione: (2024)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
di: Rachel R. Jin, et al.
Pubblicazione: (2025)

Plasma p‐tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach
di: Giorgia Brodini, et al.
Pubblicazione: (2026)

Establishment and verification of reference intervals for Alzheimer's disease plasma biomarkers based on evaluation of pre‐analytical procedures: a multicenter study
di: Wencan Jiang, et al.
Pubblicazione: (2025)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
di: Andrée‐Ann Baril, et al.
Pubblicazione: (2024)

Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum
di: Mohammed Alghamdi, et al.
Pubblicazione: (2026)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
di: Marijke E. Stokkel, et al.
Pubblicazione: (2026)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
di: John T. O'Brien
Pubblicazione: (2025)

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
di: Dejia Yin, et al.
Pubblicazione: (2026)